Book Cover
Home  |   Healthcare   |  Veterinary Orthopedic Implants Market

Veterinary Orthopedic Implants Market Size, Share, Growth, and Industry Analysis, By Type (Plates,Screws,Pins & Wires & Staples,Joint Replacement Implants), By Application (Dog,Cat,Horse,Others), Regional Insights and Forecast to 2035

Trust Icon
1000+
GLOBAL LEADERS TRUST US

Veterinary Orthopedic Implants Market Overview

The global Veterinary Orthopedic Implants Market is forecast to expand from USD 220.35 million in 2026 to USD 243.05 million in 2027, and is expected to reach USD 532.46 million by 2035, growing at a CAGR of 10.3% over the forecast period.

The Veterinary Orthopedic Implants Market Analysis covers implantable plates, screws, pins, wires, staples and joint replacement implants used across companion and large animals, with implants representing approximately 60% of the overall veterinary orthopedics product mix in 2024 and instrumentation/consumables the remaining 40%. Canine orthopedics accounts for roughly 47–50% of implant procedures by volume, while equine and feline segments contribute approximately 22% and 8% respectively; other species make up the remaining 20%. Industry reports show more than 10,000 veterinary surgical centres routinely perform orthopedic procedures and over 130,000 veterinarians are registered in developed markets, per the Veterinary Orthopedic Implants Market Report.

The USA Veterinary Orthopedic Implants Market Outlook is shaped by large companion-animal populations: approximately 89.7 million dogs and 61 million cats in 2024, and more than 130,000 licensed veterinarians, of whom roughly 20–25% perform orthopedic procedures. Annual canine cruciate ligament (CCL) repairs and fracture surgeries number in the tens of thousands—surveys indicate board-certified specialists log hundreds to thousands of procedures annually across networks—driving consumable purchase cycles of 10–500 implants per practice per year. The U.S. comprises about 40–45% of global veterinary implant demand volume, a key datapoint for the Veterinary Orthopedic Implants Market Research Report.

Global Veterinary Orthopedic Implants Market Size,

Get Comprehensive Insights into the Market’s Size and Growth Trends

downloadDownload FREE Sample

Key Findings

  • Key Market Driver: Increased pet ownership and ageing pet demographics—US households with dogs reached 68–90 million, and pet insurance penetration rose by 20–30% in selected markets—driving surgical volumes.
  • Major Market Restraint: Price sensitivity in emerging markets with roughly 30–40% of clinics preferring lower-cost reusable instruments over single-use implants due to budget constraints.
  • Emerging Trends: Approximately 35–45% of new product launches in 2023–2024 focused on patient-matched implants, 3D printed components, or bioresorbable materials.
  • Regional Leadership: North America accounts for roughly 38–45% of implant volumes, Europe 25–30%, Asia-Pacific 18–22%, and the rest of world about 7–10%.
  • Competitive Landscape: The top two veterinary implant suppliers hold an estimated 30–40% share of the specialty implant segment, while the top five control about 60–70% of the market.
  • Market Segmentation: Plates and screws together represent about 40–50% of implant volumes, pins/wires/staples 25–30%, and joint replacement implants 15–25% depending on species mix.
  • Recent Development: In 2023–2024, roughly 25–35% of veterinary clinics upgraded to locking plate systems and 12–18% adopted pre-contoured, species-specific implant lines.

The Veterinary Orthopedic Implants Market Trends show strong uptake of advanced implant systems: locking plate technology accounted for approximately 30–40% of plate shipments in 2024, with pre-contoured plates for canine femoral and tibial fixation representing 22% of plate SKUs. Use of bioresorbable pins and screws increased to near 8–12% of specific fracture repair cases in 2023, while custom 3D-printed implants comprised roughly 2–4% of joint replacement volumes but grew by 50–70% year-on-year in select specialty centres. Canine cruciate ligament repair remains the most frequent orthopedic indication, constituting about 40–50% of orthopedic case volume in many referral hospitals; fracture fixation and patellar luxation together add another 30–35% of surgical workload.

Veterinary Orthopedic Implants Market Dynamics

DRIVER

"Rising pet population, pet insurance and specialty care adoption"

The main driver of Veterinary Orthopedic Implants Market Growth is demographic and economic: global dog and cat populations exceed 150–160 million combined in major markets, and pet insurance adoption grew by approximately 20–30% in the last three years in markets such as the UK, Sweden and the Netherlands. Specialty referral centres—and an estimated 1,300–2,000 board-certified veterinary surgeons worldwide—performed the majority of complex orthopedic interventions, with referral centres often conducting 100–500 orthopedic cases annually.

RESTRAINT

"Cost pressures and reimbursement variability"

A restraint in the Veterinary Orthopedic Implants Market is the variability of pet insurance and owner willingness to pay: in markets where pet insurance penetration remains below 10–15%, clinics report price-led treatment selection with roughly 30–40% of owners choosing conservative management over surgery due to cost. Emerging markets show a preference for low-cost generic implants and reusable instrumentation; approximately 35% of smaller clinics procure locally produced plates and pins rather than premium branded systems.

OPPORTUNITY

"Technological innovation and training services"

Opportunities in the Veterinary Orthopedic Implants Market include the rapid adoption of 3D printing—custom implants for complex revision or large-breed fractures accounted for roughly 2–4% of joint replacement cases in 2024 but exhibited double-digit growth—and the integration of navigation and minimally invasive plate osteosynthesis (MIPO) approaches used in approximately 10–15% of advanced referral cases. Training and certification programmes are an increasing revenue stream: over 120 manufacturer-sponsored cadaver labs and wet-lab events were held globally in 2023, training more than 2,500 clinicians.

CHALLENGE

"Regulatory complexity and instrument sterilization protocols"

A major challenge for the Veterinary Orthopedic Implants Industry is heterogeneity of regulatory pathways: while some countries accept veterinary implants under medical device frameworks with defined classifications and traceability requirements, others have minimal specific regulation, making distributor strategies inconsistent; approximately 30–40% of exporters report varying documentation requirements that add 2–8 weeks to lead times. Sterilization and reusable instrument lifecycle management impose operational demands: instrument trays often require 6–12 sterilization cycles per week in high-throughput centres, with instrument failure rates under 0.5–1% acceptable for quality programs.

Veterinary Orthopedic Implants Market Segmentation

Global Veterinary Orthopedic Implants Market Size, 2035 (USD Million)

Get Comprehensive Insights on the Market Segmentation in this Report

download Download FREE Sample

Segmentation in the Veterinary Orthopedic Implants Market divides by implant type and animal application; plates, screws, pins/wires/staples and joint replacement implants form major product groups, while application splits include dog, cat, horse and other species. Plates and screws account for approximately 40–50% of implant volumes, pins/wires/staples for 25–30%, and joint replacements roughly 15–25%.

BY TYPE

Plates: Plates are the backbone of fracture fixation in veterinary orthopedics, representing approximately 25–30% of implant units in 2024 with locking plate sets accounting for 30–40% of plate demand. Plate systems range from 1.0–8.0 mm sizes: small-animal plates (1.0–3.5 mm) represent about 60–70% of plate sales by SKU count, while large-animal plates (4.5–8.0 mm) make up 30–40% of revenue-equivalent volumes.

The Plates segment is valued at USD 67.92 million in 2025 and expected to reach USD 170.78 million by 2034, growing at a CAGR of 10.5% and accounting for 34% market share globally.

Top 5 Major Dominant Countries in the Plates Segment:

  • United States: From USD 23.50 million in 2025 to USD 60.04 million by 2034, expanding at a CAGR of 10.6% and holding 34.6% share.
  • Germany: Estimated at USD 7.42 million in 2025, to reach USD 18.91 million by 2034, growing at 10.3% CAGR and capturing 11% share.
  • United Kingdom: From USD 6.30 million in 2025 to USD 15.89 million by 2034, advancing at 10.2% CAGR and accounting for 9% share.
  • Japan: Valued at USD 5.75 million in 2025, projected to hit USD 14.18 million by 2034, growing at 10.4% CAGR, contributing 8.3% share.
  • France: Expected to grow from USD 4.61 million in 2025 to USD 11.78 million by 2034, expanding at 10.1% CAGR and holding 6.8% share.

Screws: Screws are used in nearly every fixation construct and represent approximately 15–20% of implant unit volumes; cortical screws, cancellous screws and locking head screws are common, with sizes from 1.5 mm to 8.0 mm. In small-animal practice, screws in the 2.0–3.5 mm range make up roughly 65% of screw orders, and self-tapping vs pre-drilled screws are split nearly 50:50 depending on surgeon preference.

The Screws segment is projected at USD 51.94 million in 2025, anticipated to reach USD 124.91 million by 2034, growing at a CAGR of 10.0% and representing 26% share of the total market.

Top 5 Major Dominant Countries in the Screws Segment:

  • United States: From USD 17.54 million in 2025 to USD 42.35 million by 2034, growing at 10.1% CAGR, and holding 33.8% share.
  • Germany: Valued at USD 6.11 million in 2025, to reach USD 14.45 million by 2034, expanding at 9.9% CAGR, maintaining 11.5% share.
  • United Kingdom: From USD 5.32 million in 2025 to USD 12.48 million by 2034, growing at 10.0% CAGR, accounting for 10.2% share.
  • Japan: Estimated at USD 4.79 million in 2025, reaching USD 11.52 million by 2034, expanding at 10.1% CAGR, contributing 9.2% share.
  • Australia: From USD 3.89 million in 2025 to USD 9.34 million by 2034, growing at 9.8% CAGR, accounting for 7.5% share.

Pins, Wires & Staples: Pins, K-wires and cerclage wires together comprise about 20–30% of implant units by count, particularly important in small bone fixation and fracture tension band constructs. K-wire diameters commonly range from 0.8 mm to 2.5 mm, and kits include 10–50 wires; cerclage and stainless steel wire sets include reels of 5–30 m cuts per case.

The Pins & Wires & Staples segment is valued at USD 39.95 million in 2025, projected to reach USD 94.76 million by 2034, registering a CAGR of 10.1% and comprising 20% share of the global market.

Top 5 Major Dominant Countries in the Pins & Wires & Staples Segment:

  • United States: Estimated at USD 13.84 million in 2025, reaching USD 33.02 million by 2034, growing at 10.2% CAGR, and holding 34.6% share.
  • Germany: From USD 4.26 million in 2025 to USD 10.12 million by 2034, expanding at 9.9% CAGR, accounting for 10.6% share.
  • United Kingdom: Valued at USD 3.79 million in 2025, to reach USD 9.14 million by 2034, at 10.0% CAGR, contributing 9.7% share.
  • Japan: From USD 3.45 million in 2025 to USD 8.17 million by 2034, with 10.1% CAGR, capturing 8.7% share.
  • Canada: Estimated at USD 2.92 million in 2025, projected to hit USD 6.90 million by 2034, at 9.8% CAGR, holding 7.3% share.

Joint Replacement Implants: Joint replacement implants, including femoral head/neck replacements and total hip or elbow arthroplasty components, comprise approximately 15–25% of implant revenues in specialty centres but only 2–6% of unit counts due to high per-case implant counts and lower case volumes.

The Joint Replacement Implants segment is forecasted to grow from USD 39.96 million in 2025 to USD 92.31 million by 2034, with a CAGR of 9.9% and representing 20% of the total market share.

Top 5 Major Dominant Countries in the Joint Replacement Implants Segment:

  • United States: Valued at USD 14.10 million in 2025, reaching USD 32.65 million by 2034, growing at 9.9% CAGR, contributing 35.3% share.
  • Germany: From USD 3.95 million in 2025 to USD 9.25 million by 2034, expanding at 10.0% CAGR, capturing 10.7% share.
  • France: Estimated at USD 3.55 million in 2025, to reach USD 8.29 million by 2034, growing at 9.8% CAGR, holding 9% share.
  • Japan: From USD 3.28 million in 2025 to USD 7.48 million by 2034, advancing at 10.0% CAGR, maintaining 8.4% share.
  • United Kingdom: Valued at USD 2.94 million in 2025, projected to hit USD 6.74 million by 2034, growing at 9.7% CAGR, contributing 7.3% share.

BY APPLICATION

Dog: Dogs represent the largest animal application in the Veterinary Orthopedic Implants Market, accounting for approximately 47–50% of total procedure volume; common indications include cranial cruciate ligament rupture (around 30–40% of canine orthopedic cases), patellar luxation (10–15%), fractures (20–25%) and joint disease requiring replacement (2–5%).

The Dog segment dominates the market, valued at USD 119.86 million in 2025, reaching USD 289.66 million by 2034, growing at a CAGR of 10.2% and representing 60% share.

Top 5 Major Dominant Countries in the Dog Application:

  • United States: From USD 42.65 million in 2025 to USD 104.62 million by 2034, at 10.3% CAGR, holding 35.5% share.
  • Germany: Valued at USD 10.23 million in 2025, to reach USD 24.63 million by 2034, expanding at 10.1% CAGR, with 8.5% share.
  • United Kingdom: From USD 9.06 million in 2025 to USD 21.76 million by 2034, growing at 10.0% CAGR, maintaining 7.5% share.
  • Japan: Estimated at USD 7.95 million in 2025, reaching USD 19.13 million by 2034, advancing at 10.2% CAGR, contributing 6.6% share.
  • France: From USD 7.12 million in 2025 to USD 16.97 million by 2034, growing at 10.1% CAGR, holding 5.9% share.

Cat: Cats account for about 8–12% of veterinary orthopedic implant procedures and mostly require small fixation devices: pins, K-wires and small plates in 1.0–2.5 mm sizes represent 70–80% of feline implant units. Cat fractures and luxations lead to lower per-case implant counts (typically 2–6 implants per case), and feline arthroplasty remains rare (<1% of cases).

The Cat segment is expected to be worth USD 39.95 million in 2025, rising to USD 98.42 million by 2034, at a CAGR of 10.5% and holding 20% market share.

Top 5 Major Dominant Countries in the Cat Application:

  • United States: From USD 14.02 million in 2025 to USD 34.18 million by 2034, expanding at 10.6% CAGR, representing 35% share.
  • Germany: Valued at USD 3.72 million in 2025, to reach USD 9.01 million by 2034, growing at 10.3% CAGR, holding 9% share.
  • United Kingdom: From USD 3.38 million in 2025 to USD 8.14 million by 2034, at 10.2% CAGR, contributing 8% share.
  • Japan: Estimated at USD 3.00 million in 2025, to reach USD 7.25 million by 2034, expanding at 10.4% CAGR, accounting for 7% share.
  • France: From USD 2.64 million in 2025 to USD 6.33 million by 2034, at 10.1% CAGR, maintaining 6% share.

Horse: Horses represent a high-value but lower-volume portion of the market—equine orthopedic implants account for roughly 18–25% of implant revenue share but fewer units due to large, heavy components. Equine fracture repair often requires plates >10–20 mm in width, cortical screws 8.0–14.0 mm, and multiple locking constructs; a single equine fixation case can involve 10–50 major implants and an instrument set weighing 20–60 kg.

The Horse segment is valued at USD 29.96 million in 2025, projected to hit USD 70.63 million by 2034, with a CAGR of 10.0%, representing 15% share of the market.

Top 5 Major Dominant Countries in the Horse Application:

  • United States: From USD 10.47 million in 2025 to USD 24.70 million by 2034, at 10.1% CAGR, with 35% share.
  • Germany: Valued at USD 2.69 million in 2025, to reach USD 6.35 million by 2034, at 10.0% CAGR, maintaining 9% share.
  • France: From USD 2.45 million in 2025 to USD 5.77 million by 2034, at 9.9% CAGR, accounting for 8% share.
  • Australia: Estimated at USD 2.10 million in 2025, to reach USD 4.95 million by 2034, growing at 10.1% CAGR, capturing 7% share.
  • United Kingdom: From USD 1.95 million in 2025 to USD 4.66 million by 2034, advancing at 10.0% CAGR, holding 6.5% share.

Others: Other species—including rabbits, exotic mammals, birds and small ruminants—represent approximately 10–15% of implant volumes, and implants for these species are specialized: small gauge pins, microplates and unique fixation staples are used, with implant counts typically ranging from 1–10 per case.

The Others segment accounts for USD 9.99 million in 2025, projected to reach USD 23.05 million by 2034, with a CAGR of 9.8%, representing 5% market share.

Top 5 Major Dominant Countries in the Others Application:

  • United States: Valued at USD 3.45 million in 2025, to reach USD 7.98 million by 2034, growing at 9.9% CAGR, capturing 34% share.
  • Germany: From USD 1.12 million in 2025 to USD 2.55 million by 2034, expanding at 9.7% CAGR, accounting for 11% share.
  • United Kingdom: Estimated at USD 0.95 million in 2025, reaching USD 2.13 million by 2034, with 9.6% CAGR, maintaining 9% share.
  • Japan: From USD 0.86 million in 2025 to USD 1.98 million by 2034, at 9.8% CAGR, contributing 8% share.
  • France: Valued at USD 0.78 million in 2025, to reach USD 1.83 million by 2034, growing at 9.7% CAGR, holding 7% share.

Veterinary Orthopedic Implants Market Regional Outlook

Global Veterinary Orthopedic Implants Market Share, by Type 2035

Get Comprehensive Insights into the Market’s Size and Growth Trends

download Download FREE Sample

Regional dynamics in the Veterinary Orthopedic Implants Market show North America leading with about 38–45% of implant volumes, Europe at 25–30%, Asia-Pacific 18–22%, and Latin America + MEA at 7–10%. North America and Europe favour premium branded implants and advanced arthroplasty, while Asia-Pacific and LAMEA place higher weight on cost-efficient implants and growing specialty services.

NORTH AMERICA

North America dominates the Veterinary Orthopedic Implants Market with approximately 38–45% of global implant unit volumes in 2024, driven by a large companion animal population—estimated 89.7 million dogs and 61 million cats—and high specialty care penetration. The region has over 130,000 licensed veterinarians and several thousand specialty and referral hospitals, where top centres report 100–500 orthopedic procedures annually.

The North America Veterinary Orthopedic Implants Market is projected to grow from USD 90.89 million in 2025 to USD 222.59 million by 2034, at a CAGR of 10.4%, representing 45% of the global market share.

North America - Major Dominant Countries in the “Veterinary Orthopedic Implants Market”:

  • United States: From USD 73.82 million in 2025 to USD 182.19 million by 2034, growing at 10.5% CAGR, holding 81% regional share.
  • Canada: Valued at USD 9.13 million in 2025, reaching USD 21.64 million by 2034, expanding at 10.3% CAGR, maintaining 10% share.
  • Mexico: From USD 4.45 million in 2025 to USD 10.54 million by 2034, at 10.0% CAGR, holding 5% share.
  • Cuba: Estimated at USD 1.72 million in 2025, to reach USD 4.02 million by 2034, growing at 9.9% CAGR, with 2% share.
  • Dominican Republic: From USD 1.12 million in 2025 to USD 2.58 million by 2034, expanding at 9.8% CAGR, maintaining 1% share.

EUROPE

Europe holds roughly 25–30% of the Veterinary Orthopedic Implants Market with national variations in implant use and regulatory standards; countries such as the U.K., Germany, France and the Netherlands account for the majority of referral centres performing arthroplasty and complex fracture fixation. 

The Europe market is forecasted to increase from USD 57.93 million in 2025 to USD 134.71 million by 2034, at a CAGR of 10.1%, representing 28% of global share.

Europe - Major Dominant Countries in the “Veterinary Orthopedic Implants Market”:

  • Germany: From USD 14.38 million in 2025 to USD 33.83 million by 2034, growing at 10.2% CAGR, contributing 25% share.
  • United Kingdom: Valued at USD 12.14 million in 2025, reaching USD 28.23 million by 2034, expanding at 10.1% CAGR, maintaining 21% share.
  • France: From USD 10.56 million in 2025 to USD 24.13 million by 2034, at 10.0% CAGR, holding 18% share.
  • Italy: Estimated at USD 9.06 million in 2025, to reach USD 20.77 million by 2034, at 9.9% CAGR, with 15% share.
  • Spain: From USD 7.91 million in 2025 to USD 17.75 million by 2034, growing at 9.8% CAGR, accounting for 13% share.

ASIA-PACIFIC

Asia-Pacific accounts for approximately 18–22% of global Veterinary Orthopedic Implants Market volumes in 2024, with China, India, Japan and South Korea leading growth. Increased urban pet ownership—millions of new companion animals registered in metropolitan areas—drove orthopedic case volumes up by 15–25% year-on-year in many urban referral centres. 

The Asia market is valued at USD 35.96 million in 2025, projected to reach USD 89.72 million by 2034, growing at a CAGR of 10.4%, accounting for 18% global share.

Asia - Major Dominant Countries in the “Veterinary Orthopedic Implants Market”:

  • Japan: From USD 11.92 million in 2025 to USD 29.65 million by 2034, with 10.3% CAGR, contributing 33% share.
  • China: Valued at USD 10.53 million in 2025, to reach USD 26.20 million by 2034, at 10.5% CAGR, holding 29% share.
  • India: From USD 6.65 million in 2025 to USD 16.53 million by 2034, growing at 10.2% CAGR, maintaining 18% share.
  • South Korea: Estimated at USD 3.29 million in 2025, reaching USD 8.01 million by 2034, at 10.3% CAGR, comprising 9% share.
  • Australia: From USD 3.57 million in 2025 to USD 9.33 million by 2034, expanding at 10.4% CAGR, accounting for 10% share.

MIDDLE EAST & AFRICA

Middle East & Africa, combined with Latin America, represent around 7–10% of global veterinary orthopedic implant volumes, with adoption concentrated in private clinics and specialty hospitals in affluent urban centres. In GCC countries, private referral hospitals report 500–1,500 orthopedic procedures annually per multi-site group, and high per-case implant use for equine and canine surgeries results in large, infrequent orders—single procurement events for equine implant sets may exceed 20–50 high-grade implants.

The Middle East & Africa market is forecasted to grow from USD 14.99 million in 2025 to USD 35.74 million by 2034, with a CAGR of 10.0%, contributing 9% global share.

Middle East and Africa - Major Dominant Countries in the “Veterinary Orthopedic Implants Market”:

  • Saudi Arabia: Valued at USD 4.05 million in 2025, to reach USD 9.75 million by 2034, with 10.1% CAGR, holding 27% share.
  • United Arab Emirates: From USD 3.27 million in 2025 to USD 7.85 million by 2034, growing at 10.0% CAGR, maintaining 22% share.
  • South Africa: Estimated at USD 2.86 million in 2025, to reach USD 6.85 million by 2034, expanding at 9.9% CAGR, accounting for 19% share.
  • Egypt: From USD 2.43 million in 2025 to USD 5.84 million by 2034, at 9.8% CAGR, holding 16% share.
  • Qatar: Valued at USD 1.62 million in 2025, to reach USD 3.45 million by 2034, with 9.7% CAGR, contributing 10% share.

List of Top Veterinary Orthopedic Implants Companies

  • DePuy Synthes Vet
  • Scil Animal Care
  • Intrauma
  • Braun Vet Care
  • BioMedtrix
  • Orthomed UK
  • Veterinary Orthopedic Implants
  • SECUROS Surgical
  • IMEX Veterinary
  • Sophiatech
  • Ortho
  • NGD
  • KYON
  • INNOPLANT Medizintechnik GmbH
  • Bluesao

DePuy Synthes Vet: estimated to hold roughly 18–22% share of global specialty implant distribution in 2024, shipping hundreds of implant kits to referral centres and maintaining instrument loaner programmes in over 25 countries.

BioMedtrix: estimated around 10–14% share in joint replacement and specialty implant segments, with established hip replacement systems used in 50–200 cases per major referral hospital annually.

Investment Analysis and Opportunities

Investment analysis in the Veterinary Orthopedic Implants Market highlights near-term opportunities in consumable manufacturing expansion, digital surgical planning, and training services. Demand drivers support investments in implant SKU production capacity where monthly output increases of 10–30% can meet rising reorder rates; for example, scaling a manufacturing line to produce an additional 20,000–50,000 screws and 2,000–5,000 plate sets monthly targets common clinic reorder volumes. 

New Product Development

New product development is centered on lightweight locking plate systems, bioresorbable fixation, patient-matched implants and integrated digital planning. In 2023–2024, about 35–45% of R&D pipelines for veterinary implant companies targeted locking plate refinements and pre-contoured, breed-specific plates; such plates reduced intraoperative contouring time by roughly 25–35%. Bioresorbable pins and screws achieved penetration of 8–12% in selected small-animal fracture repairs, providing the advantage of avoiding second surgeries for implant removal in ~30–40% of indicated cases.

Five Recent Developments

  • Q2 2023: A leading supplier introduced a pre-contoured locking plate family for small breeds with plate angles in 3 size ranges and achieved adoption in 120 referral centres in year one.
  • Q4 2023: A manufacturer launched a bioresorbable pin/screw set cleared for select fracture types; early adopter centres reported ~30% of eligible cases transitioned away from metallic implants.
  • Q3 2024: Several tertiary hospitals implemented 3D-printed patient-matched implants for complex pelvic reconstructions; cumulative cases numbered over 50 across 10 centres in the first 12 months.
  • Q2 2024: An OEM expanded its distribution network to add 6 regional warehouses, reducing average delivery times from 21 days to 7–10 days for core implant SKUs.
  • Q1 2025: A consortium launched a pan-regional training programme certifying clinicians after 5–10 supervised cases; 350 clinicians achieved certification within 6 months, increasing procedural adoption in affiliated clinics.

Report Coverage of Veterinary Orthopedic Implants Market

This Veterinary Orthopedic Implants Market Research Report covers historical trends (2018–2023), a current-state analysis for 2024–2025, and a forward-looking Veterinary Orthopedic Implants Market Forecast through 2032, segmented by product type (plates, screws, pins/wires/staples, joint replacements), by application (dog, cat, horse, others), and by region (North America, Europe, Asia-Pacific, LAMEA). It quantifies procedure volumes and implant unit demand—e.g., dogs represent about 47–50% of surgical volumes, plates and screws account for 40–50% of implants, and tertiary referral centres may perform 100–500 orthopedic cases annually.

Veterinary Orthopedic Implants Market Report Coverage

REPORT COVERAGE DETAILS

Market Size Value In

USD 220.35 Million in 2026

Market Size Value By

USD 532.46 Million by 2035

Growth Rate

CAGR of 10.3% from 2026 - 2035

Forecast Period

2026 - 2035

Base Year

2025

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type :

  • Plates
  • Screws
  • Pins & Wires & Staples
  • Joint Replacement Implants

By Application :

  • Dog
  • Cat
  • Horse
  • Others

To Understand the Detailed Market Report Scope & Segmentation

download Download FREE Sample

Frequently Asked Questions

The global Veterinary Orthopedic Implants Market is expected to reach USD 532.46 Million by 2035.

The Veterinary Orthopedic Implants Market is expected to exhibit a CAGR of 10.3% by 2035.

DePuy Synthes Vet,Scil animal care,Intrauma,B.Braun Vet Care,BioMedtrix,Orthomed UK,Veterinary Orthopedic Implants,SECUROS Surgical,IMEX Veterinary,Sophiatech,Ortho,NGD,KYON,INNOPLANT Medizintechnik GmbH,Bluesao.

In 2025, the Veterinary Orthopedic Implants Market value stood at USD 199.77 Million.

faq right

Our Clients

Captcha refresh

Trusted & Certified